Diamond Power Infrastructure Limited
Diamond Power Infrastructure Limited (DIACABS.NS) Stock Competitors & Peer Comparison
See (DIACABS.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DIACABS.NS | ₹137.09 | +2.54% | 70B | 67.08 | ₹1.98 | N/A |
| ABB.NS | ₹6,859.50 | +4.49% | 1.4T | 83.73 | ₹78.99 | +0.65% |
| ABB.BO | ₹6,865.95 | +4.59% | 1.4T | 79.32 | ₹83.38 | +0.65% |
| CUMMINSIND.NS | ₹5,138.70 | +7.14% | 1.4T | 60.54 | ₹81.06 | +1.09% |
| CUMMINSIND.BO | ₹5,137.85 | +7.05% | 1.4T | 60.52 | ₹81.08 | +1.09% |
| SIEMENS.NS | ₹3,388.50 | +5.03% | 1.1T | 68.04 | ₹47.36 | N/A |
| SIEMENS.BO | ₹3,390.10 | +5.03% | 1.1T | 67.98 | ₹47.37 | N/A |
| BHEL.NS | ₹284.71 | +7.15% | 965.2B | 118.46 | ₹2.34 | +0.18% |
| BHEL.BO | ₹284.65 | +7.09% | 964.9B | 118.42 | ₹2.34 | +0.18% |
| VOLTAS.BO | ₹1,315.15 | +4.06% | 425B | 84.50 | ₹15.20 | +0.55% |
Stock Comparison
DIACABS.NS vs ABB.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ABB.NS has a market cap of 1.4T. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ABB.NS trades at ₹6,859.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ABB.NS's P/E ratio is 83.73. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ABB.NS's ROE of +0.23%. Regarding short-term risk, DIACABS.NS is more volatile compared to ABB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ABB.NS's competition here
DIACABS.NS vs ABB.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ABB.BO has a market cap of 1.4T. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ABB.BO trades at ₹6,865.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ABB.BO's P/E ratio is 79.32. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ABB.BO's ROE of +0.23%. Regarding short-term risk, DIACABS.NS is more volatile compared to ABB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ABB.BO's competition here
DIACABS.NS vs CUMMINSIND.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, CUMMINSIND.NS has a market cap of 1.4T. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while CUMMINSIND.NS trades at ₹5,138.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas CUMMINSIND.NS's P/E ratio is 60.54. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to CUMMINSIND.NS's ROE of +0.30%. Regarding short-term risk, DIACABS.NS is less volatile compared to CUMMINSIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check CUMMINSIND.NS's competition here
DIACABS.NS vs CUMMINSIND.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, CUMMINSIND.BO has a market cap of 1.4T. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while CUMMINSIND.BO trades at ₹5,137.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas CUMMINSIND.BO's P/E ratio is 60.52. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to CUMMINSIND.BO's ROE of +0.30%. Regarding short-term risk, DIACABS.NS is less volatile compared to CUMMINSIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check CUMMINSIND.BO's competition here
DIACABS.NS vs SIEMENS.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, SIEMENS.NS has a market cap of 1.1T. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while SIEMENS.NS trades at ₹3,388.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas SIEMENS.NS's P/E ratio is 68.04. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to SIEMENS.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.NS is less volatile compared to SIEMENS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check SIEMENS.NS's competition here
DIACABS.NS vs SIEMENS.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, SIEMENS.BO has a market cap of 1.1T. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while SIEMENS.BO trades at ₹3,390.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas SIEMENS.BO's P/E ratio is 67.98. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to SIEMENS.BO's ROE of +0.13%. Regarding short-term risk, DIACABS.NS is less volatile compared to SIEMENS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check SIEMENS.BO's competition here
DIACABS.NS vs BHEL.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, BHEL.NS has a market cap of 965.2B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while BHEL.NS trades at ₹284.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas BHEL.NS's P/E ratio is 118.46. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to BHEL.NS's ROE of +0.03%. Regarding short-term risk, DIACABS.NS is more volatile compared to BHEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check BHEL.NS's competition here
DIACABS.NS vs BHEL.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, BHEL.BO has a market cap of 964.9B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while BHEL.BO trades at ₹284.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas BHEL.BO's P/E ratio is 118.42. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to BHEL.BO's ROE of +0.03%. Regarding short-term risk, DIACABS.NS is more volatile compared to BHEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check BHEL.BO's competition here
DIACABS.NS vs VOLTAS.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, VOLTAS.BO has a market cap of 425B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while VOLTAS.BO trades at ₹1,315.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas VOLTAS.BO's P/E ratio is 84.50. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to VOLTAS.BO's ROE of +0.08%. Regarding short-term risk, DIACABS.NS is more volatile compared to VOLTAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check VOLTAS.BO's competition here
DIACABS.NS vs VOLTAS.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, VOLTAS.NS has a market cap of 424.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while VOLTAS.NS trades at ₹1,315.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas VOLTAS.NS's P/E ratio is 84.75. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to VOLTAS.NS's ROE of +0.08%. Regarding short-term risk, DIACABS.NS is more volatile compared to VOLTAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check VOLTAS.NS's competition here
DIACABS.NS vs THERMAX.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, THERMAX.NS has a market cap of 398.2B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while THERMAX.NS trades at ₹3,643.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas THERMAX.NS's P/E ratio is 58.51. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to THERMAX.NS's ROE of +0.14%. Regarding short-term risk, DIACABS.NS is more volatile compared to THERMAX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check THERMAX.NS's competition here
DIACABS.NS vs THERMAX.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, THERMAX.BO has a market cap of 398.2B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while THERMAX.BO trades at ₹3,645.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas THERMAX.BO's P/E ratio is 58.53. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to THERMAX.BO's ROE of +0.14%. Regarding short-term risk, DIACABS.NS is more volatile compared to THERMAX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check THERMAX.BO's competition here
DIACABS.NS vs GET&D.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, GET&D.NS has a market cap of 397.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while GET&D.NS trades at ₹1,552.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas GET&D.NS's P/E ratio is 100.73. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to GET&D.NS's ROE of +0.27%. Regarding short-term risk, DIACABS.NS is less volatile compared to GET&D.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check GET&D.NS's competition here
DIACABS.NS vs BLUESTARCO.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, BLUESTARCO.NS has a market cap of 340.4B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while BLUESTARCO.NS trades at ₹1,690.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas BLUESTARCO.NS's P/E ratio is 69.01. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to BLUESTARCO.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to BLUESTARCO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check BLUESTARCO.NS's competition here
DIACABS.NS vs AIAENG.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, AIAENG.BO has a market cap of 339B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while AIAENG.BO trades at ₹3,775.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas AIAENG.BO's P/E ratio is 29.15. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to AIAENG.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to AIAENG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check AIAENG.BO's competition here
DIACABS.NS vs AIAENG.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, AIAENG.NS has a market cap of 338.9B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while AIAENG.NS trades at ₹3,773.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas AIAENG.NS's P/E ratio is 29.24. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to AIAENG.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to AIAENG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check AIAENG.NS's competition here
DIACABS.NS vs KAYNES.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KAYNES.NS has a market cap of 258.2B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KAYNES.NS trades at ₹3,896.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KAYNES.NS's P/E ratio is 62.32. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KAYNES.NS's ROE of +0.12%. Regarding short-term risk, DIACABS.NS is more volatile compared to KAYNES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KAYNES.NS's competition here
DIACABS.NS vs KAYNES.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KAYNES.BO has a market cap of 258.2B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KAYNES.BO trades at ₹3,897.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KAYNES.BO's P/E ratio is 64.99. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KAYNES.BO's ROE of +0.12%. Regarding short-term risk, DIACABS.NS is more volatile compared to KAYNES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KAYNES.BO's competition here
DIACABS.NS vs SCHNEIDER.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, SCHNEIDER.NS has a market cap of 231.2B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while SCHNEIDER.NS trades at ₹1,010.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas SCHNEIDER.NS's P/E ratio is 93.96. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to SCHNEIDER.NS's ROE of +0.45%. Regarding short-term risk, DIACABS.NS is less volatile compared to SCHNEIDER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check SCHNEIDER.NS's competition here
DIACABS.NS vs KIRLOSENG.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KIRLOSENG.BO has a market cap of 212B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KIRLOSENG.BO trades at ₹1,471.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KIRLOSENG.BO's P/E ratio is 39.08. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KIRLOSENG.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLOSENG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLOSENG.BO's competition here
DIACABS.NS vs KIRLOSENG.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KIRLOSENG.NS has a market cap of 211.9B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KIRLOSENG.NS trades at ₹1,473.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KIRLOSENG.NS's P/E ratio is 39.01. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KIRLOSENG.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLOSENG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLOSENG.NS's competition here
DIACABS.NS vs LAXMIMACH.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, LAXMIMACH.BO has a market cap of 185.2B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while LAXMIMACH.BO trades at ₹17,338.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas LAXMIMACH.BO's P/E ratio is 63.86. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to LAXMIMACH.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.NS is more volatile compared to LAXMIMACH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LAXMIMACH.BO's competition here
DIACABS.NS vs LAXMIMACH.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, LAXMIMACH.NS has a market cap of 185.1B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while LAXMIMACH.NS trades at ₹17,324.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas LAXMIMACH.NS's P/E ratio is 63.45. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to LAXMIMACH.NS's ROE of +0.15%. Regarding short-term risk, DIACABS.NS is less volatile compared to LAXMIMACH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check LAXMIMACH.NS's competition here
DIACABS.NS vs JYOTICNC.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, JYOTICNC.NS has a market cap of 183.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while JYOTICNC.NS trades at ₹819.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas JYOTICNC.NS's P/E ratio is 0.75. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to JYOTICNC.NS's ROE of +0.21%. Regarding short-term risk, DIACABS.NS is more volatile compared to JYOTICNC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check JYOTICNC.NS's competition here
DIACABS.NS vs ELGIEQUIP.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ELGIEQUIP.BO has a market cap of 157.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ELGIEQUIP.BO trades at ₹512.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ELGIEQUIP.BO's P/E ratio is 39.12. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ELGIEQUIP.BO's ROE of +0.22%. Regarding short-term risk, DIACABS.NS is more volatile compared to ELGIEQUIP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ELGIEQUIP.BO's competition here
DIACABS.NS vs ELGIEQUIP.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ELGIEQUIP.NS has a market cap of 157.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ELGIEQUIP.NS trades at ₹512.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ELGIEQUIP.NS's P/E ratio is 39.15. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ELGIEQUIP.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.NS is more volatile compared to ELGIEQUIP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ELGIEQUIP.NS's competition here
DIACABS.NS vs KSB.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KSB.NS has a market cap of 149.7B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KSB.NS trades at ₹893.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KSB.NS's P/E ratio is 55.47. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KSB.NS's ROE of +0.00%. Regarding short-term risk, DIACABS.NS is more volatile compared to KSB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KSB.NS's competition here
DIACABS.NS vs KSB.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KSB.BO has a market cap of 149.7B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KSB.BO trades at ₹892.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KSB.BO's P/E ratio is 55.29. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KSB.BO's ROE of +0.00%. Regarding short-term risk, DIACABS.NS is more volatile compared to KSB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KSB.BO's competition here
DIACABS.NS vs TRITURBINE.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, TRITURBINE.BO has a market cap of 144.7B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while TRITURBINE.BO trades at ₹460.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas TRITURBINE.BO's P/E ratio is 42.25. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to TRITURBINE.BO's ROE of +0.30%. Regarding short-term risk, DIACABS.NS is more volatile compared to TRITURBINE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TRITURBINE.BO's competition here
DIACABS.NS vs TRITURBINE.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, TRITURBINE.NS has a market cap of 144.6B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while TRITURBINE.NS trades at ₹460.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas TRITURBINE.NS's P/E ratio is 42.24. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to TRITURBINE.NS's ROE of +0.30%. Regarding short-term risk, DIACABS.NS is more volatile compared to TRITURBINE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TRITURBINE.NS's competition here
DIACABS.NS vs LMW.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, LMW.NS has a market cap of 142.9B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while LMW.NS trades at ₹13,662.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas LMW.NS's P/E ratio is 124.31. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to LMW.NS's ROE of +0.04%. Regarding short-term risk, DIACABS.NS is more volatile compared to LMW.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LMW.NS's competition here
DIACABS.NS vs LMW.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, LMW.BO has a market cap of 142.7B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while LMW.BO trades at ₹13,662.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas LMW.BO's P/E ratio is 124.27. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to LMW.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.NS is more volatile compared to LMW.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LMW.BO's competition here
DIACABS.NS vs TDPOWERSYS.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, TDPOWERSYS.NS has a market cap of 137.1B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while TDPOWERSYS.NS trades at ₹926.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas TDPOWERSYS.NS's P/E ratio is 62.37. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to TDPOWERSYS.NS's ROE of +0.24%. Regarding short-term risk, DIACABS.NS is less volatile compared to TDPOWERSYS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check TDPOWERSYS.NS's competition here
DIACABS.NS vs TDPOWERSYS.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, TDPOWERSYS.BO has a market cap of 137.1B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while TDPOWERSYS.BO trades at ₹926.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas TDPOWERSYS.BO's P/E ratio is 62.62. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to TDPOWERSYS.BO's ROE of +0.24%. Regarding short-term risk, DIACABS.NS is less volatile compared to TDPOWERSYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check TDPOWERSYS.BO's competition here
DIACABS.NS vs TEGA.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, TEGA.BO has a market cap of 128.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while TEGA.BO trades at ₹1,728.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas TEGA.BO's P/E ratio is 57.97. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to TEGA.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.NS is more volatile compared to TEGA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TEGA.BO's competition here
DIACABS.NS vs TEGA.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, TEGA.NS has a market cap of 128.7B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while TEGA.NS trades at ₹1,727.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas TEGA.NS's P/E ratio is 56.97. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to TEGA.NS's ROE of +0.15%. Regarding short-term risk, DIACABS.NS is more volatile compared to TEGA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TEGA.NS's competition here
DIACABS.NS vs MTARTECH.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, MTARTECH.BO has a market cap of 128B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while MTARTECH.BO trades at ₹4,174.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas MTARTECH.BO's P/E ratio is 200.95. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to MTARTECH.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is less volatile compared to MTARTECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check MTARTECH.BO's competition here
DIACABS.NS vs MTARTECH.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, MTARTECH.NS has a market cap of 127.9B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while MTARTECH.NS trades at ₹4,173.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas MTARTECH.NS's P/E ratio is 201.28. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to MTARTECH.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is less volatile compared to MTARTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check MTARTECH.NS's competition here
DIACABS.NS vs KIRLOSBROS.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KIRLOSBROS.BO has a market cap of 121.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KIRLOSBROS.BO trades at ₹1,588.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KIRLOSBROS.BO's P/E ratio is 30.96. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KIRLOSBROS.BO's ROE of +0.19%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLOSBROS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLOSBROS.BO's competition here
DIACABS.NS vs KIRLOSBROS.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KIRLOSBROS.NS has a market cap of 121.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KIRLOSBROS.NS trades at ₹1,588.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KIRLOSBROS.NS's P/E ratio is 30.44. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KIRLOSBROS.NS's ROE of +0.19%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLOSBROS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLOSBROS.NS's competition here
DIACABS.NS vs INGERRAND.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, INGERRAND.NS has a market cap of 119.9B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while INGERRAND.NS trades at ₹3,888.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas INGERRAND.NS's P/E ratio is 46.24. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to INGERRAND.NS's ROE of +0.41%. Regarding short-term risk, DIACABS.NS is more volatile compared to INGERRAND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check INGERRAND.NS's competition here
DIACABS.NS vs INGERRAND.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, INGERRAND.BO has a market cap of 119.9B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while INGERRAND.BO trades at ₹3,893.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas INGERRAND.BO's P/E ratio is 45.34. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to INGERRAND.BO's ROE of +0.41%. Regarding short-term risk, DIACABS.NS is more volatile compared to INGERRAND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check INGERRAND.BO's competition here
DIACABS.NS vs INOXINDIA.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, INOXINDIA.NS has a market cap of 111.1B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while INOXINDIA.NS trades at ₹1,305.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas INOXINDIA.NS's P/E ratio is 44.78. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to INOXINDIA.NS's ROE of +0.29%. Regarding short-term risk, DIACABS.NS is less volatile compared to INOXINDIA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check INOXINDIA.NS's competition here
DIACABS.NS vs AZAD.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, AZAD.NS has a market cap of 108B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while AZAD.NS trades at ₹1,704.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas AZAD.NS's P/E ratio is 87.27. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to AZAD.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.NS is more volatile compared to AZAD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check AZAD.NS's competition here
DIACABS.NS vs ELECON.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ELECON.BO has a market cap of 95.6B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ELECON.BO trades at ₹419.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ELECON.BO's P/E ratio is 19.85. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ELECON.BO's ROE of +0.24%. Regarding short-term risk, DIACABS.NS is less volatile compared to ELECON.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check ELECON.BO's competition here
DIACABS.NS vs ELECON.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ELECON.NS has a market cap of 95.6B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ELECON.NS trades at ₹419.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ELECON.NS's P/E ratio is 19.82. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ELECON.NS's ROE of +0.24%. Regarding short-term risk, DIACABS.NS is less volatile compared to ELECON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check ELECON.NS's competition here
DIACABS.NS vs VESUVIUS.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, VESUVIUS.NS has a market cap of 92.6B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while VESUVIUS.NS trades at ₹460.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas VESUVIUS.NS's P/E ratio is 35.09. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to VESUVIUS.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to VESUVIUS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check VESUVIUS.NS's competition here
DIACABS.NS vs VESUVIUS.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, VESUVIUS.BO has a market cap of 92.6B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while VESUVIUS.BO trades at ₹459.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas VESUVIUS.BO's P/E ratio is 35.03. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to VESUVIUS.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to VESUVIUS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check VESUVIUS.BO's competition here
DIACABS.NS vs KIRLPNU.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KIRLPNU.BO has a market cap of 76.3B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KIRLPNU.BO trades at ₹1,202.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KIRLPNU.BO's P/E ratio is 39.22. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KIRLPNU.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLPNU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLPNU.BO's competition here
DIACABS.NS vs KIRLPNU.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KIRLPNU.NS has a market cap of 76.3B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KIRLPNU.NS trades at ₹1,204.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KIRLPNU.NS's P/E ratio is 40.05. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KIRLPNU.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLPNU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLPNU.NS's competition here
DIACABS.NS vs ISGEC.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ISGEC.NS has a market cap of 70.1B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ISGEC.NS trades at ₹1,001.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ISGEC.NS's P/E ratio is 21.11. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ISGEC.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is less volatile compared to ISGEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check ISGEC.NS's competition here
DIACABS.NS vs DIACABS.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, DIACABS.BO has a market cap of 70B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while DIACABS.BO trades at ₹137.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas DIACABS.BO's P/E ratio is 67.07. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to DIACABS.BO's ROE of -0.12%. Regarding short-term risk, DIACABS.NS is more volatile compared to DIACABS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check DIACABS.BO's competition here
DIACABS.NS vs ISGEC.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ISGEC.BO has a market cap of 69.9B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ISGEC.BO trades at ₹1,001.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ISGEC.BO's P/E ratio is 21.05. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ISGEC.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is less volatile compared to ISGEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check ISGEC.BO's competition here
DIACABS.NS vs SHAKTIPUMP.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, SHAKTIPUMP.NS has a market cap of 63.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while SHAKTIPUMP.NS trades at ₹510.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas SHAKTIPUMP.NS's P/E ratio is 19.02. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to SHAKTIPUMP.NS's ROE of +0.27%. Regarding short-term risk, DIACABS.NS is more volatile compared to SHAKTIPUMP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SHAKTIPUMP.NS's competition here
DIACABS.NS vs SHAKTIPUMP.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, SHAKTIPUMP.BO has a market cap of 63.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while SHAKTIPUMP.BO trades at ₹510.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas SHAKTIPUMP.BO's P/E ratio is 19.01. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to SHAKTIPUMP.BO's ROE of +0.27%. Regarding short-term risk, DIACABS.NS is more volatile compared to SHAKTIPUMP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SHAKTIPUMP.BO's competition here
DIACABS.NS vs LLOYDSENGG.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, LLOYDSENGG.BO has a market cap of 58.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while LLOYDSENGG.BO trades at ₹49.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas LLOYDSENGG.BO's P/E ratio is 41.42. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to LLOYDSENGG.BO's ROE of +0.22%. Regarding short-term risk, DIACABS.NS is less volatile compared to LLOYDSENGG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check LLOYDSENGG.BO's competition here
DIACABS.NS vs LLOYDSENGG.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, LLOYDSENGG.NS has a market cap of 58.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while LLOYDSENGG.NS trades at ₹49.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas LLOYDSENGG.NS's P/E ratio is 41.42. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to LLOYDSENGG.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.NS is less volatile compared to LLOYDSENGG.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check LLOYDSENGG.NS's competition here
DIACABS.NS vs BALUFORGE.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, BALUFORGE.BO has a market cap of 53.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while BALUFORGE.BO trades at ₹466.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas BALUFORGE.BO's P/E ratio is 21.11. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to BALUFORGE.BO's ROE of +0.24%. Regarding short-term risk, DIACABS.NS is more volatile compared to BALUFORGE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check BALUFORGE.BO's competition here
DIACABS.NS vs DIAPOWER.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, DIAPOWER.NS has a market cap of 52.6B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while DIAPOWER.NS trades at ₹195.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas DIAPOWER.NS's P/E ratio is -1.78. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to DIAPOWER.NS's ROE of +0.05%. Regarding short-term risk, DIACABS.NS is less volatile compared to DIAPOWER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check DIAPOWER.NS's competition here
DIACABS.NS vs LSIL.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, LSIL.NS has a market cap of 52.1B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while LSIL.NS trades at ₹48.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas LSIL.NS's P/E ratio is 130.41. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to LSIL.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.NS is more volatile compared to LSIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LSIL.NS's competition here
DIACABS.NS vs GMMPFAUDLR.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, GMMPFAUDLR.BO has a market cap of 40.1B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while GMMPFAUDLR.BO trades at ₹911.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas GMMPFAUDLR.BO's P/E ratio is 227.67. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to GMMPFAUDLR.BO's ROE of -0.02%. Regarding short-term risk, DIACABS.NS is more volatile compared to GMMPFAUDLR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check GMMPFAUDLR.BO's competition here
DIACABS.NS vs GMMPFAUDLR.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, GMMPFAUDLR.NS has a market cap of 40B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while GMMPFAUDLR.NS trades at ₹912.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas GMMPFAUDLR.NS's P/E ratio is 228.82. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to GMMPFAUDLR.NS's ROE of +0.02%. Regarding short-term risk, DIACABS.NS is more volatile compared to GMMPFAUDLR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check GMMPFAUDLR.NS's competition here
DIACABS.NS vs TEXRAIL.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, TEXRAIL.NS has a market cap of 39.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while TEXRAIL.NS trades at ₹98.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas TEXRAIL.NS's P/E ratio is 21.99. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to TEXRAIL.NS's ROE of +0.06%. Regarding short-term risk, DIACABS.NS is more volatile compared to TEXRAIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TEXRAIL.NS's competition here
DIACABS.NS vs TEXRAIL.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, TEXRAIL.BO has a market cap of 39.4B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while TEXRAIL.BO trades at ₹98.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas TEXRAIL.BO's P/E ratio is 21.98. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to TEXRAIL.BO's ROE of +0.06%. Regarding short-term risk, DIACABS.NS is more volatile compared to TEXRAIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TEXRAIL.BO's competition here
DIACABS.NS vs WPIL.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, WPIL.BO has a market cap of 38.9B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while WPIL.BO trades at ₹408.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas WPIL.BO's P/E ratio is 32.59. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to WPIL.BO's ROE of +0.08%. Regarding short-term risk, DIACABS.NS is more volatile compared to WPIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check WPIL.BO's competition here
DIACABS.NS vs ANUP.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ANUP.NS has a market cap of 37.3B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ANUP.NS trades at ₹1,919.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ANUP.NS's P/E ratio is 32.48. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ANUP.NS's ROE of +0.19%. Regarding short-term risk, DIACABS.NS is less volatile compared to ANUP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check ANUP.NS's competition here
DIACABS.NS vs ANUP.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ANUP.BO has a market cap of 37.3B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ANUP.BO trades at ₹1,910.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ANUP.BO's P/E ratio is 32.50. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ANUP.BO's ROE of +0.19%. Regarding short-term risk, DIACABS.NS is less volatile compared to ANUP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check ANUP.BO's competition here
DIACABS.NS vs SHANTIGEAR.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, SHANTIGEAR.BO has a market cap of 35.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while SHANTIGEAR.BO trades at ₹462.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas SHANTIGEAR.BO's P/E ratio is 42.93. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to SHANTIGEAR.BO's ROE of +0.21%. Regarding short-term risk, DIACABS.NS is more volatile compared to SHANTIGEAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SHANTIGEAR.BO's competition here
DIACABS.NS vs SHANTIGEAR.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, SHANTIGEAR.NS has a market cap of 35.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while SHANTIGEAR.NS trades at ₹461.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas SHANTIGEAR.NS's P/E ratio is 42.87. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to SHANTIGEAR.NS's ROE of +0.21%. Regarding short-term risk, DIACABS.NS is more volatile compared to SHANTIGEAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SHANTIGEAR.NS's competition here
DIACABS.NS vs GREAVESCOT.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, GREAVESCOT.BO has a market cap of 34.2B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while GREAVESCOT.BO trades at ₹150.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas GREAVESCOT.BO's P/E ratio is 32.97. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to GREAVESCOT.BO's ROE of +0.07%. Regarding short-term risk, DIACABS.NS is more volatile compared to GREAVESCOT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check GREAVESCOT.BO's competition here
DIACABS.NS vs GREAVESCOT.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, GREAVESCOT.NS has a market cap of 34.2B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while GREAVESCOT.NS trades at ₹150.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas GREAVESCOT.NS's P/E ratio is 31.67. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to GREAVESCOT.NS's ROE of +0.07%. Regarding short-term risk, DIACABS.NS is more volatile compared to GREAVESCOT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check GREAVESCOT.NS's competition here
DIACABS.NS vs SGLTL.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, SGLTL.NS has a market cap of 27.4B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while SGLTL.NS trades at ₹137.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas SGLTL.NS's P/E ratio is 38.46. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to SGLTL.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.NS is more volatile compared to SGLTL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SGLTL.NS's competition here
DIACABS.NS vs SETL.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, SETL.NS has a market cap of 26.4B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while SETL.NS trades at ₹132.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas SETL.NS's P/E ratio is 35.15. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to SETL.NS's ROE of +0.08%. Regarding short-term risk, DIACABS.NS is more volatile compared to SETL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SETL.NS's competition here
DIACABS.NS vs KLBRENG-B.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KLBRENG-B.BO has a market cap of 25.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KLBRENG-B.BO trades at ₹496.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KLBRENG-B.BO's P/E ratio is 26.21. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KLBRENG-B.BO's ROE of +0.20%. Regarding short-term risk, DIACABS.NS is more volatile compared to KLBRENG-B.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KLBRENG-B.BO's competition here
DIACABS.NS vs JASH.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, JASH.NS has a market cap of 25.1B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while JASH.NS trades at ₹402.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas JASH.NS's P/E ratio is 44.26. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to JASH.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.NS is more volatile compared to JASH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check JASH.NS's competition here
DIACABS.NS vs GMM.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, GMM.BO has a market cap of 22.9B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while GMM.BO trades at ₹1,563.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas GMM.BO's P/E ratio is 31.46. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to GMM.BO's ROE of -0.02%. Regarding short-term risk, DIACABS.NS is more volatile compared to GMM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check GMM.BO's competition here
DIACABS.NS vs WINDMACHIN.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, WINDMACHIN.BO has a market cap of 21.6B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while WINDMACHIN.BO trades at ₹258.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas WINDMACHIN.BO's P/E ratio is -775.16. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to WINDMACHIN.BO's ROE of -0.02%. Regarding short-term risk, DIACABS.NS is less volatile compared to WINDMACHIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check WINDMACHIN.BO's competition here
DIACABS.NS vs HONDAPOWER.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, HONDAPOWER.NS has a market cap of 21.6B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while HONDAPOWER.NS trades at ₹2,158.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas HONDAPOWER.NS's P/E ratio is 29.37. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to HONDAPOWER.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is less volatile compared to HONDAPOWER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check HONDAPOWER.NS's competition here
DIACABS.NS vs PENIND.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, PENIND.BO has a market cap of 21.6B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while PENIND.BO trades at ₹163.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas PENIND.BO's P/E ratio is 16.17. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to PENIND.BO's ROE of +0.13%. Regarding short-term risk, DIACABS.NS is more volatile compared to PENIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check PENIND.BO's competition here
DIACABS.NS vs WINDMACHIN.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, WINDMACHIN.NS has a market cap of 21.6B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while WINDMACHIN.NS trades at ₹258.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas WINDMACHIN.NS's P/E ratio is -773.53. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to WINDMACHIN.NS's ROE of -0.02%. Regarding short-term risk, DIACABS.NS is less volatile compared to WINDMACHIN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check WINDMACHIN.NS's competition here
DIACABS.NS vs PENIND.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, PENIND.NS has a market cap of 21.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while PENIND.NS trades at ₹163.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas PENIND.NS's P/E ratio is 15.81. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to PENIND.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.NS is more volatile compared to PENIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check PENIND.NS's competition here
DIACABS.NS vs HONDAPOWER.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, HONDAPOWER.BO has a market cap of 21.5B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while HONDAPOWER.BO trades at ₹2,158.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas HONDAPOWER.BO's P/E ratio is 29.30. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to HONDAPOWER.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is more volatile compared to HONDAPOWER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check HONDAPOWER.BO's competition here
DIACABS.NS vs KMEW.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, KMEW.BO has a market cap of 20.7B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while KMEW.BO trades at ₹1,775.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas KMEW.BO's P/E ratio is 60.46. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to KMEW.BO's ROE of +0.30%. Regarding short-term risk, DIACABS.NS is more volatile compared to KMEW.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KMEW.BO's competition here
DIACABS.NS vs HLEGLAS.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, HLEGLAS.NS has a market cap of 20.4B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while HLEGLAS.NS trades at ₹299.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas HLEGLAS.NS's P/E ratio is 30.09. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to HLEGLAS.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.NS is more volatile compared to HLEGLAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check HLEGLAS.NS's competition here
DIACABS.NS vs HLEGLAS.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, HLEGLAS.BO has a market cap of 20.4B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while HLEGLAS.BO trades at ₹299.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas HLEGLAS.BO's P/E ratio is 30.07. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to HLEGLAS.BO's ROE of +0.10%. Regarding short-term risk, DIACABS.NS is more volatile compared to HLEGLAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check HLEGLAS.BO's competition here
DIACABS.NS vs PIXTRANS.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, PIXTRANS.NS has a market cap of 19.9B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while PIXTRANS.NS trades at ₹1,450.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas PIXTRANS.NS's P/E ratio is 18.18. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to PIXTRANS.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to PIXTRANS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check PIXTRANS.NS's competition here
DIACABS.NS vs PIXTRANS.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, PIXTRANS.BO has a market cap of 19.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while PIXTRANS.BO trades at ₹1,450.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas PIXTRANS.BO's P/E ratio is 18.15. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to PIXTRANS.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to PIXTRANS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check PIXTRANS.BO's competition here
DIACABS.NS vs ADVAIT.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ADVAIT.BO has a market cap of 19.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ADVAIT.BO trades at ₹1,865.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ADVAIT.BO's P/E ratio is 43.57. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ADVAIT.BO's ROE of +0.23%. Regarding short-term risk, DIACABS.NS is more volatile compared to ADVAIT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ADVAIT.BO's competition here
DIACABS.NS vs DISAQ.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, DISAQ.BO has a market cap of 17.7B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while DISAQ.BO trades at ₹12,188.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas DISAQ.BO's P/E ratio is 33.18. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to DISAQ.BO's ROE of +0.20%. Regarding short-term risk, DIACABS.NS is more volatile compared to DISAQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check DISAQ.BO's competition here
DIACABS.NS vs THEJO.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, THEJO.NS has a market cap of 17.2B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while THEJO.NS trades at ₹1,638.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas THEJO.NS's P/E ratio is 35.43. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to THEJO.NS's ROE of +0.16%. Regarding short-term risk, DIACABS.NS is less volatile compared to THEJO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check THEJO.NS's competition here
DIACABS.NS vs LXMIATO.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, LXMIATO.BO has a market cap of 16.6B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while LXMIATO.BO trades at ₹2,483.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas LXMIATO.BO's P/E ratio is 584.15. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to LXMIATO.BO's ROE of +0.01%. Regarding short-term risk, DIACABS.NS is less volatile compared to LXMIATO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check LXMIATO.BO's competition here
DIACABS.NS vs ADOR.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ADOR.BO has a market cap of 15.3B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ADOR.BO trades at ₹891.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ADOR.BO's P/E ratio is 23.19. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ADOR.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is less volatile compared to ADOR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check ADOR.BO's competition here
DIACABS.NS vs ADOR.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ADOR.NS has a market cap of 15.2B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ADOR.NS trades at ₹893.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ADOR.NS's P/E ratio is 23.33. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ADOR.NS's ROE of +0.14%. Regarding short-term risk, DIACABS.NS is less volatile compared to ADOR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check ADOR.NS's competition here
DIACABS.NS vs ADORWELD.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ADORWELD.NS has a market cap of 14.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ADORWELD.NS trades at ₹852.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ADORWELD.NS's P/E ratio is 33.22. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ADORWELD.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to ADORWELD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ADORWELD.NS's competition here
DIACABS.NS vs ADORWELD.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, ADORWELD.BO has a market cap of 14.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while ADORWELD.BO trades at ₹852.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas ADORWELD.BO's P/E ratio is 24.67. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to ADORWELD.BO's ROE of +0.02%. Regarding short-term risk, DIACABS.NS is more volatile compared to ADORWELD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ADORWELD.BO's competition here
DIACABS.NS vs JNKINDIA.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, JNKINDIA.NS has a market cap of 14.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while JNKINDIA.NS trades at ₹275.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas JNKINDIA.NS's P/E ratio is 32.31. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to JNKINDIA.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is more volatile compared to JNKINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check JNKINDIA.NS's competition here
DIACABS.NS vs JYOTISTRUC.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, JYOTISTRUC.BO has a market cap of 13.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while JYOTISTRUC.BO trades at ₹11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas JYOTISTRUC.BO's P/E ratio is 25.73. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to JYOTISTRUC.BO's ROE of +0.11%. Regarding short-term risk, DIACABS.NS is more volatile compared to JYOTISTRUC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check JYOTISTRUC.BO's competition here
DIACABS.NS vs JYOTISTRUC.NS Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, JYOTISTRUC.NS has a market cap of 13.8B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while JYOTISTRUC.NS trades at ₹11.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas JYOTISTRUC.NS's P/E ratio is 26.25. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to JYOTISTRUC.NS's ROE of +0.11%. Regarding short-term risk, DIACABS.NS is more volatile compared to JYOTISTRUC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check JYOTISTRUC.NS's competition here
DIACABS.NS vs EKC.BO Comparison April 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 70B. In comparison, EKC.BO has a market cap of 12.3B. Regarding current trading prices, DIACABS.NS is priced at ₹137.09, while EKC.BO trades at ₹111.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 67.08, whereas EKC.BO's P/E ratio is 12.73. In terms of profitability, DIACABS.NS's ROE is -0.12%, compared to EKC.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is more volatile compared to EKC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check EKC.BO's competition here